Litcius/Paper detail

Iridium-catalyzed C−H methylation and d3-methylation of benzoic acids with application to late-stage functionalizations

Erik Weis, Martin A. Hayes, Magnus J. Johansson, Belén Martín‐Matute

2021iScience36 citationsDOIOpen Access PDF

Abstract

Late-stage functionalization (LSF) has over the past years emerged as a powerful approach in the drug discovery process. At its best, it allows for rapid access to new analogues from a single drug-like molecule, bypassing the need for de novo synthesis. To be successful, methods able to tolerate the diverse functional groups present in drug-like molecules that perform under mild conditions are required. C−H methylation is of particular interest due to the magic methyl effec t in medicinal chemistry. Herein we report an iridium-catalyzed carboxylate-directed ortho C−H methylation and d 3 -methylation of benzoic acids. The method uses commercially available reagents and precatalyst and requires no inert atmosphere or exclusion of moisture. Substrates bearing electron-rich and electron-poor groups were successfully methylated, including compounds with competing directing/coordinating groups. The method was also applied to the LSF of several marketed drugs, forming analogues with increased metabolic stability compared with the parent drug.

Topics & Concepts

IridiumMethylationDrug discoveryCombinatorial chemistryChemistryCatalysisComputational biologyOrganic chemistryBiologyBiochemistryGeneCatalytic C–H Functionalization MethodsCatalytic Cross-Coupling ReactionsAsymmetric Hydrogenation and Catalysis
Iridium-catalyzed C−H methylation and d3-methylation of benzoic acids with application to late-stage functionalizations | Litcius